MedWatch

Leo Pharma invested USD 70 million in biotech firm facing patent lawsuit

A US hospital claims the right to several patents that form the basis of biotech company Pellepharm's absolute main asset. Danish Leo Pharma signed a million-dollar deal with the firm in November last year.

A patent suit in California, US, is threatening US biotech firm Pellepharm, in which Danish company Leo Pharma recently invested millions.

Pellepharm co-founder and CFO, Ervin Epstein, has been sued by his former employer that claims the right to several of the patents on Pellepharm's absolute lead candidate, patidegib.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier